Silverarc Capital Management as of March 31, 2025
Portfolio Holdings for Silverarc Capital Management
Silverarc Capital Management holds 69 positions in its portfolio as reported in the March 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Verona Pharma Sponsored Ads (VRNA) | 7.1 | $35M | 546k | 63.49 | |
| Merus N V (MRUS) | 7.0 | $34M | 811k | 42.09 | |
| Nuvalent Inc-a (NUVL) | 6.4 | $31M | 439k | 70.92 | |
| Akero Therapeutics (AKRO) | 6.0 | $29M | 720k | 40.48 | |
| Insmed Com Par $.01 (INSM) | 5.0 | $25M | 321k | 76.29 | |
| Kalvista Pharmaceuticals (KALV) | 4.0 | $20M | 1.7M | 11.54 | |
| Veracyte (VCYT) | 3.8 | $19M | 634k | 29.65 | |
| Rhythm Pharmaceuticals (RYTM) | 3.7 | $18M | 338k | 52.97 | |
| Syndax Pharmaceuticals (SNDX) | 3.3 | $16M | 1.3M | 12.29 | |
| Urogen Pharma (URGN) | 3.1 | $15M | 1.4M | 11.06 | |
| Avidity Biosciences Ord (RNA) | 2.5 | $12M | 411k | 29.52 | |
| Soleno Therapeutics (SLNO) | 2.4 | $12M | 166k | 71.45 | |
| Ascendis Pharma A/s Sponsored Adr (ASND) | 2.4 | $12M | 76k | 155.86 | |
| Disc Medicine (IRON) | 2.4 | $12M | 237k | 49.64 | |
| Oric Pharmaceuticals (ORIC) | 2.4 | $12M | 2.1M | 5.58 | |
| 89bio (ETNB) | 2.2 | $11M | 1.5M | 7.27 | |
| Erasca (ERAS) | 2.1 | $10M | 7.4M | 1.37 | |
| Wave Life Sciences SHS (WVE) | 1.7 | $8.5M | 1.1M | 8.08 | |
| Neurocrine Biosciences (NBIX) | 1.6 | $8.0M | 73k | 110.60 | |
| Travere Therapeutics (TVTX) | 1.5 | $7.3M | 409k | 17.92 | |
| Akero Therapeutics Call Call Option | 1.5 | $7.3M | 181k | 40.48 | |
| Gossamer Bio (GOSS) | 1.4 | $7.0M | 6.3M | 1.10 | |
| Gilead Sciences (GILD) | 1.4 | $7.0M | 62k | 112.05 | |
| Helix Acquisition Corp Ii Cl A Ord Shs (HLXB) | 1.4 | $6.9M | 613k | 11.30 | |
| Elutia Cl A Com (ELUT) | 1.4 | $6.8M | 2.7M | 2.53 | |
| Praxis Precision Medicines I Com New (PRAX) | 1.3 | $6.3M | 166k | 37.87 | |
| Mineralys Therapeutics (MLYS) | 1.1 | $5.4M | 338k | 15.88 | |
| Compugen Ord (CGEN) | 0.9 | $4.2M | 2.9M | 1.46 | |
| Tarsus Pharmaceuticals (TARS) | 0.9 | $4.2M | 81k | 51.37 | |
| Alkermes SHS (ALKS) | 0.8 | $4.1M | 125k | 33.02 | |
| Ocular Therapeutix (OCUL) | 0.8 | $4.0M | 552k | 7.33 | |
| Bridgebio Pharma (BBIO) | 0.8 | $3.8M | 111k | 34.57 | |
| Kura Oncology (KURA) | 0.8 | $3.8M | 581k | 6.60 | |
| Celldex Therapeutics Com New (CLDX) | 0.8 | $3.7M | 206k | 18.15 | |
| Dianthus Therapeutics (DNTH) | 0.7 | $3.5M | 190k | 18.14 | |
| Madrigal Pharmaceuticals (MDGL) | 0.7 | $3.4M | 10k | 331.23 | |
| Cerus Corporation (CERS) | 0.7 | $3.4M | 2.5M | 1.39 | |
| Tela Bio (TELA) | 0.7 | $3.4M | 2.8M | 1.22 | |
| Centessa Pharmaceuticals Sponsored Ads (CNTA) | 0.7 | $3.3M | 233k | 14.38 | |
| Trevi Therapeutics (TRVI) | 0.7 | $3.3M | 530k | 6.29 | |
| Blueprint Medicines (BPMC) | 0.7 | $3.3M | 37k | 88.51 | |
| Structure Therapeutics Sponsored Ads (GPCR) | 0.7 | $3.3M | 188k | 17.31 | |
| Benitec Biopharma Com New (BNTC) | 0.7 | $3.3M | 250k | 13.01 | |
| Liquidia Corporation Com New (LQDA) | 0.6 | $3.2M | 214k | 14.75 | |
| Ptc Therapeutics I (PTCT) | 0.6 | $3.1M | 60k | 50.96 | |
| Mestera (MTSR) | 0.6 | $3.1M | 113k | 27.22 | |
| Soleno Therapeutics Put Put Option | 0.6 | $3.0M | 43k | 71.45 | |
| Biodesix (BDSX) | 0.5 | $2.6M | 4.1M | 0.63 | |
| Delcath Sys Com New (DCTH) | 0.5 | $2.4M | 192k | 12.73 | |
| Uniqure Nv SHS (QURE) | 0.4 | $2.2M | 203k | 10.60 | |
| Kiniksa Pharmaceuticals Intl Ord Shs Cl A (KNSA) | 0.4 | $2.0M | 88k | 22.21 | |
| Solid Biosciences Com New (SLDB) | 0.3 | $1.7M | 452k | 3.70 | |
| Compass Therapeutics (CMPX) | 0.3 | $1.7M | 875k | 1.90 | |
| C4 Therapeutics Com Stk (CCCC) | 0.3 | $1.4M | 882k | 1.60 | |
| Kala Bio Com New (KALA) | 0.3 | $1.4M | 246k | 5.73 | |
| Unicycive Therapeutics | 0.3 | $1.4M | 2.4M | 0.57 | |
| Abivax Sa Sponsored Ads (ABVX) | 0.3 | $1.3M | 211k | 6.25 | |
| Kodiak Sciences (KOD) | 0.3 | $1.2M | 442k | 2.81 | |
| Sionna Therapeutics (SION) | 0.2 | $1.2M | 114k | 10.46 | |
| Inflarx Nv (IFRX) | 0.2 | $1.2M | 1.2M | 1.02 | |
| Mersana Therapeutics | 0.2 | $1.1M | 3.1M | 0.34 | |
| Modular Med Com New (MODD) | 0.2 | $1.0M | 959k | 1.09 | |
| Radiopharm Theranostics Sponsored Ads (RADX) | 0.2 | $901k | 187k | 4.81 | |
| Aardvark Therapeutics (AARD) | 0.2 | $897k | 120k | 7.51 | |
| Xenon Pharmaceuticals (XENE) | 0.1 | $340k | 10k | 33.55 | |
| Avadel Pharmaceuticals Com Shs (AVDL) | 0.1 | $308k | 39k | 7.83 | |
| Fractyl Health (GUTS) | 0.1 | $283k | 237k | 1.19 | |
| Vaxart Com New (VXRT) | 0.1 | $278k | 684k | 0.41 | |
| Rocket Pharmaceuticals *w Exp 09/02/202 (RCKTW) | 0.0 | $4.9k | 105k | 0.05 |